Clinical TrialsSearch results
Number of results: 2195
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A Study of TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)
- Primary Immunodeficiency Diseases (PID)
- Nishizawa Atsushi
- 2021-11-27
Completed
- A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma
- Lymphoma, Non-Hodgkin
- Nakayama Ippei
- 2021-04-27
Completed
- A study of the clinical effects of 6-MSITC on chronic fatigue syndrome
- myalgic encephalomyelitis/chronic fatigue syndrome
- Oka Takakazu
- 2020-02-12
Completed
- A study of the usefulness of Ninjinyoeito for hypotrophic patients
- Hypotrophic
- Asaoka Daisuke
- 2022-03-18
Completed
- A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants
- Systemic Lupus Erythematosus
- Kitahara Yasumi
- 2021-01-20
Completed
- A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma Initially Treated with an Injection of Proteasome Inhibitor-Based Therapy
- Relapsed and/or Refractory Multiple Myeloma
- Abe Yu
- 2018-07-19
Completed
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Nagashima Masahito
- 2020-10-26
Completed
- A study to eveluate the safety of MR19D6A
- Cancerous cutaneous ulcers
- Oya Nobuyo
- 2021-01-06
Completed
- A study to find a safe and effective dose of BI 1701963 alone and in combination with BI 3011441 in patients with advanced cancer and a certain mutation (Kirsten rat sarcoma viral oncogene homologue [KRAS])
- KRAS mutation positive solid tumours (Parts A and B), KRAS mutation positive NSCLC and CRC (Parts C
- WU HAOYU
- 2021-03-01
Completed
- A study to test different doses of BI 836880 combined with ezabenlimab in patients with advanced non-small cell lung cancer followed by other types of advanced solid tumours
- advanced solid tumours
- Yamagami Tomohiro
- 2020-11-18